Guardian Pharmacy Services, Inc. reported $1.46B of revenue over the trailing twelve months, +10% on the year before. 7 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.46B (to Q2 2026). Net Income: $66M, trailing twelve months to Q2 2026. Op Margin: 5.8%, trailing twelve months to Q2 2026.

GRDNGuardian Pharmacy Services, Inc.

HealthcareUSD

$37.49

$19.8852 weeks$43.62

GRDN as reported

Guardian Pharmacy Services, Inc. reported $1.46B of revenue over the trailing twelve months, +10% on the year before. 7 reported series are charted on this page, each one as filed.

$1.46B

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net Income: $66M
Net Income · −172% year on year · trailing twelve months to Q2 2026
Op Margin: 5.8%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for GRDN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.46B	+10%	Q2 2026
Net Income	$66M	−172%	Q2 2026
Gross Margin	22%	n/a	Q2 2026
Op Margin	5.8%	n/a	Q2 2026
Net Margin	4.5%	n/a	Q2 2026
ROE	23%	n/a	Q2 2026
ROA	12%	n/a	Q2 2026